Thomas McGonigal

ABT-888, an Orally Active Poly(ADP-Ribose) Polymerase Inhibitor that Potentiates DNA-Damaging Agents in Preclinical Tumor Models

Cherrie K. Donawho, Yan Luo, Yanping Luo et al. · Clinical Cancer Research · 2007 · 762 citations · Full text

Potent and selective inhibitors of Akt kinases slow the progress of tumors <i>in vivo</i>

Yan Luo, Alexander R. Shoemaker, Xuesong Liu et al. · Molecular Cancer Therapeutics · 2005 · 244 citations · Full text

Akt Kinases, Signal Transduction Pathways, Medicine +14

LRRC15 Is a Novel Mesenchymal Protein and Stromal Target for Antibody–Drug Conjugates

James W. Purcell, Sonia G. Tanlimco, Jonathan A. Hickson et al. · Cancer Research · 2018 · 189 citations

Akt inhibitor A-443654 induces rapid Akt Ser-473 phosphorylation independent of mTORC1 inhibition

En-Kun Han, Thomas McGonigal, O. Jameel Shah et al. · Oncogene · 2007 · 169 citations

Molecular Pharmacology, Signal Transduction, Molecular Physiology +8

Survivin Enhances Aurora-B Kinase Activity and Localizes Aurora-B in Human Cells

Jun Chen, Sha Jin, Stephen K. Tahir et al. · Journal of Biological Chemistry · 2002 · 121 citations · Full text